Latest Peptide Research
Stay informed about the latest research and developments
Filter Articles
Structural analysis of modified GRF 1-29 (Mod GRF) examining amino acid substitutions enhancing stability and potency. Investigates GHRH receptor binding dynamics and resistance to enzymatic degradation in biochemical assays.
Clinical review examining thymosin beta-4 (TB-500) applications in tissue repair and regeneration. Explores actin-sequestering properties, cell migration enhancement, and anti-inflammatory effects in wound healing and cardiovascular repair models.
Recent research on Semax: Effect of ACTH4-10Pro8-Gly9-Pro10 on anti-inflammatory cytokine (IL-4, IL-10, IL-13) expression in acute spinal cord injury models (male Sprague Dawley rats).
Comprehensive review of BPC-157's wound healing applications including skin wounds, deep burns, diabetic ulcers, and alkali burns. Examines cytoprotective mechanisms, angiomodulatory effects, and practical applicability across multiple tissue types with no reported toxicity.
Foundational research examining BPC-157's therapeutic potential in hypovascular and hypocellular soft tissues including tendons and ligaments. Demonstrates beneficial effects in skeletal muscle injury models from both direct trauma and systemic insults.
Molecular study demonstrating BPC-157 dose- and time-dependently increases growth hormone receptor expression in tendon fibroblasts at both mRNA and protein levels. Reveals growth hormone activation of JAK-STAT signaling pathway in BPC-157-treated cells.
Mechanistic investigation revealing BPC-157 significantly accelerates tendon fibroblast outgrowth from explants, enhances cell survival under oxidative stress, and promotes dose-dependent migration. Demonstrates potential mechanisms underlying tendon healing enhancement.
Recent research on Oxytocin: Oxytocin.
Pioneering study investigating BPC-157's influence on granulation tissue formation, collagen production, and angiogenesis using skin incisional wounds, colon-colon anastomoses, and synthetic sponge implantation models. Demonstrates efficacy across multiple administration routes.
Recent research on L-Carnitine: 3-Hydroxyisobutyryl-CoA Hydrolase Deficiency.